Daniel Rozbesky

Dr. Daniel Rozbesky


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2020 in Nature
Verified
Journal Article
Closed access
PDF file
VMVedanta Mehta
Vedanta Mehta
KPKar-Lai Pang
Kar-Lai Pang
DRDaniel Rozbesky
Daniel Rozbesky
KNKatrin Nather
Katrin Nather
AKAdam Keen
Adam Keen
ETEllie Tzima
Ellie Tzima

7 August 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
LWLucy C. Walters
Lucy C. Walters
KHKarl Harlos
Karl Harlos
SBSimon Brackenridge
Simon Brackenridge
DRDaniel Rozbesky
Daniel Rozbesky
JBJordan R. Barrett
Jordan R. Barrett
GGGeraldine M. Gillespie
Geraldine M. Gillespie
Through major histocompatibility complex class Ia leader sequence-derived (VL9) peptide binding and CD94/NKG2 receptor engagement, human leucocyte antigen E (HLA-E) reports cellular health to NK cells. Previous studies demonstrated a strong bias for VL9 binding by HLA-E, a preference subsequently supported by structural analyses. However,Mycobacteria tuberculosis(Mtb) infection and Rhesus cytomegalovirus-vectored SIV vaccinations revealed contexts where HLA-E and the rhesus homologue, Mamu-E, presented diverse pathogen-derived peptides to CD8+T cells, respectively. Here we present crystal structures of HLA-E in complex with HIV and Mtb-derived peptides. We show that despite the presence of preferred primary anchor residues, HLA-E-bound peptides can adopt alternative conformations within the peptide binding groove. Furthermore, combined structural and mutagenesis analyses illustrate a greater tolerance for hydrophobic and polar residues in the primary pockets than previously appreciated. Finally, biochemical studies reveal HLA-E peptide binding and exchange characteristics with potential relevance to its alternative antigen presenting function in vivo.

12 December 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
DRDaniel Rozbesky
Daniel Rozbesky
MRMichal Rosulek
Michal Rosulek
ZKZdenek Kukacka
Zdenek Kukacka
JCJosef Chmelík
Josef Chmelík
PMPetr Man
Petr Man
Petr NovakPetr Novak
Petr Novak

5 June 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
DRDaniel Rozbesky
Daniel Rozbesky
MVMarieke G Verhagen
Marieke G Verhagen
DKDimple Karia
Dimple Karia
GNGergely N Nagy
Gergely N Nagy
LALuis Alvarez
Luis Alvarez
EJEdith Yvonne Jones
Edith Yvonne Jones
Semaphorin ligands interact with plexin receptors to contribute to functions in the development of myriad tissues including neurite guidance and synaptic organisation within the nervous system. Cell‐attached semaphorins interact in trans with plexins on opposing cells, but also in cis on the same cell. The interplay between trans and cis interactions is crucial for the regulated development of complex neural circuitry, but the underlying molecular mechanisms are uncharacterised. We have discovered a distinct mode of interaction through which the Drosophila semaphorin Sema1b and mouse Sema6A mediate binding in cis to their cognate plexin receptors. Our high‐resolution structural, biophysical and in vitro analyses demonstrate that monomeric semaphorins can mediate a distinctive plexin binding mode. These findings suggest the interplay between monomeric vs dimeric states has a hereto unappreciated role in semaphorin biology, providing a mechanism by which Sema6s may balance cis and trans functionalities.

23 December 2011 in Analytical Chemistry
Verified
Journal Article
Closed access
DRDaniel Rozbesky
Daniel Rozbesky
PMPetr Man
Petr Man
DKDaniel Kavan
Daniel Kavan
JCJosef Chmelik
Josef Chmelik
JCJiri Cerny
Jiri Cerny
Petr NovakPetr Novak
Petr Novak

1 September 2011 in Journal of Structural Biology
Verified
Journal Article
Closed access
PKPetr Kolenko
Petr Kolenko
DRDaniel Rozbesky
Daniel Rozbesky
Ondrej VanekOndrej Vanek
Ondrej Vanek
VKVladimír Kopecký
Vladimír Kopecký
KHKaterina Hofbauerova
Katerina Hofbauerova
JDJan Dohnálek
Jan Dohnálek